Well, it's a biotech where profitability is imminent.
Growth potential on existing products is massive.
A collaboration with a global pharma to be announced in the near future.
Phase 2 results due April which will likely lead to a Phase 3 trial.
The price is doing exactly what is should be doing.
Still very cheap now IMO
Well, it's a biotech where profitability is imminent. Growth...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.76 |
Change
-0.390(3.21%) |
Mkt cap ! $248.6M | |||
| Open | High | Low | Value | Volume |
| $12.15 | $12.27 | $11.27 | $382.7K | 32.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 420 | $11.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.85 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |